Simple view
Full metadata view
Authors
Statistics
Reimbursement legislations and decision making for orphan drugs in Central and Eastern European countries
Journal
Frontiers in Pharmacology
100
Author
Volume
10
Article ID
487
eISSN
1663-9812
Keywords in English
orphan drug
reimbursement policy
Central and East Europe
European Medicine Agency
kappa coefficient of agreement
marketing authorisation
exceptional circumstances
conditional approval
Language
English
Journal language
English
Affiliation
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego
Scopus© citations
24
cris.lastimport.wos | 2024-04-09T21:57:55Z | |
dc.affiliation | Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego | pl |
dc.cm.date | 2020-01-07 | |
dc.cm.id | 94565 | |
dc.contributor.author | Malinowski, Krzysztof | pl |
dc.contributor.author | Kawalec, Paweł - 130055 | pl |
dc.contributor.author | Trąbka, Wojciech - 133681 | pl |
dc.contributor.author | Czech, Marcin | pl |
dc.contributor.author | Petrova, Guenka | pl |
dc.contributor.author | Manova, Manoela | pl |
dc.contributor.author | Savova, Alexandra | pl |
dc.contributor.author | Draganić, Pero | pl |
dc.contributor.author | Vostalova, Lenka | pl |
dc.contributor.author | Slaby, Juraj | pl |
dc.contributor.author | Männik, Agnes | pl |
dc.contributor.author | Márky, Kristóf | pl |
dc.contributor.author | Rugaja, Zinta | pl |
dc.contributor.author | Gulbinovic, Jolanta | pl |
dc.contributor.author | Tesar, Tomas | pl |
dc.contributor.author | Paveliu, Marian Sorin | pl |
dc.date.accessioned | 2020-01-17T10:09:14Z | |
dc.date.available | 2020-01-17T10:09:14Z | |
dc.date.issued | 2019 | pl |
dc.date.openaccess | 0 | |
dc.description.accesstime | w momencie opublikowania | |
dc.description.points | 100 | pl |
dc.description.version | ostateczna wersja wydawcy | |
dc.description.volume | 10 | pl |
dc.identifier.articleid | 487 | pl |
dc.identifier.doi | 10.3389/fphar.2019.00487 | pl |
dc.identifier.eissn | 1663-9812 | |
dc.identifier.project | ROD UJ / OP | pl |
dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/146319 | |
dc.language | eng | pl |
dc.language.container | eng | pl |
dc.rights | Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa | * |
dc.rights.licence | CC-BY | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/legalcode.pl | * |
dc.share.type | otwarte czasopismo | |
dc.subject.en | orphan drug | pl |
dc.subject.en | reimbursement policy | pl |
dc.subject.en | Central and East Europe | pl |
dc.subject.en | European Medicine Agency | pl |
dc.subject.en | kappa coefficient of agreement | pl |
dc.subject.en | marketing authorisation | pl |
dc.subject.en | exceptional circumstances | pl |
dc.subject.en | conditional approval | pl |
dc.subtype | Article | pl |
dc.title | Reimbursement legislations and decision making for orphan drugs in Central and Eastern European countries | pl |
dc.title.journal | Frontiers in Pharmacology | pl |
dc.type | JournalArticle | pl |
dspace.entity.type | Publication |
cris.lastimport.wos
2024-04-09T21:57:55Z dc.affiliationpl
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego dc.cm.date
2020-01-07 dc.cm.id
94565 dc.contributor.authorpl
Malinowski, Krzysztof dc.contributor.authorpl
Kawalec, Paweł - 130055 dc.contributor.authorpl
Trąbka, Wojciech - 133681 dc.contributor.authorpl
Czech, Marcin dc.contributor.authorpl
Petrova, Guenka dc.contributor.authorpl
Manova, Manoela dc.contributor.authorpl
Savova, Alexandra dc.contributor.authorpl
Draganić, Pero dc.contributor.authorpl
Vostalova, Lenka dc.contributor.authorpl
Slaby, Juraj dc.contributor.authorpl
Männik, Agnes dc.contributor.authorpl
Márky, Kristóf dc.contributor.authorpl
Rugaja, Zinta dc.contributor.authorpl
Gulbinovic, Jolanta dc.contributor.authorpl
Tesar, Tomas dc.contributor.authorpl
Paveliu, Marian Sorin dc.date.accessioned
2020-01-17T10:09:14Z dc.date.available
2020-01-17T10:09:14Z dc.date.issuedpl
2019 dc.date.openaccess
0 dc.description.accesstime
w momencie opublikowania dc.description.pointspl
100 dc.description.version
ostateczna wersja wydawcy dc.description.volumepl
10 dc.identifier.articleidpl
487 dc.identifier.doipl
10.3389/fphar.2019.00487 dc.identifier.eissn
1663-9812 dc.identifier.projectpl
ROD UJ / OP dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/146319 dc.languagepl
eng dc.language.containerpl
eng dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa dc.rights.licence
CC-BY dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl dc.share.type
otwarte czasopismo dc.subject.enpl
orphan drug dc.subject.enpl
reimbursement policy dc.subject.enpl
Central and East Europe dc.subject.enpl
European Medicine Agency dc.subject.enpl
kappa coefficient of agreement dc.subject.enpl
marketing authorisation dc.subject.enpl
exceptional circumstances dc.subject.enpl
conditional approval dc.subtypepl
Article dc.titlepl
Reimbursement legislations and decision making for orphan drugs in Central and Eastern European countries dc.title.journalpl
Frontiers in Pharmacology dc.typepl
JournalArticle dspace.entity.type
Publication Affiliations
Wydział Nauk o Zdrowiu
Malinowski, Krzysztof
Kawalec, Paweł
No affiliation
Trąbka, Wojciech
Czech, Marcin
Petrova, Guenka
Manova, Manoela
Savova, Alexandra
Draganić, Pero
Vostalova, Lenka
Slaby, Juraj
Männik, Agnes
Márky, Kristóf
Rugaja, Zinta
Gulbinovic, Jolanta
Tesar, Tomas
Paveliu, Marian Sorin
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Open Access
Loading...